Landmark results could pave the way for miv-cel to become the first FDA-approved CAR T-cell therapy for autoimmune disease; ...
As 2025 draws to a close, 2026 looks to be another busy year in the world of accountancy and tax, with various changes being implemented and updates to ...
TipRanks on MSN
Fortress Biotech’s CUTX-101 NDA resubmission accepted by FDA
Fortress Biotech ( ($FBIO) ) has provided an announcement. On December 15, 2025, Fortress Biotech announced that the U.S. FDA accepted the ...
At the Anzá project in Colombia, Orosur holds full ownership of approximately 330km² of exploration titles in the Mid-Cauca ...
Business.com on MSN
Accounting cycle 101
The accounting cycle tracks a transaction until it's added to your company's financial statement. Follow this eight-step ...
Out of 40 monitoring stations, 11 continued to record “severe” AQI levels, while 27 areas fell in the “very poor” category.
Dyne Therapeutics, Inc.’s 2026 outlook with key DYNE-101/251 data, FDA submission plans, and extended cash runway. Click for ...
Out of the city’s 22 zones, four zones recorded collections exceeding Rs 10 crore each. These included Zone 22, Zone 16, Zone ...
Stocks like Senores Pharmaceuticals, Arvind SmartSpaces, Ion Exchange India, Zydus Lifesciences, Solex Energy, Westlife ...
Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) ('Aya” or the 'Corporation”) is pleased to announce the filing of an updated ...
NDTV Profit on MSN
Stock Market Today: All You Need To Know Going Into Trade On Dec. 16
The benchmark equity indices snapped their two-session winning streak on Monday. The NSE Nifty 50 ended 19.65 points or 0.08% ...
Ryan Serhant says he has a list of all the billionaires he’s met—all 101 of them. For the real-estate mogul whose brokerage, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback